newsfilter
← Latest News
PR Newswire·

SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Baxter International

  • Faruqi & Faruqi, LLP is investigating potential securities law violations by Baxter International Inc. (NYSE: BAX) regarding the Novum LVP infusion pump.
  • Investors who purchased Baxter securities between February 23, 2022, and July 30, 2025, may have legal claims.
  • The complaint alleges Baxter failed to disclose systemic defects in the Novum LVP causing underinfusion, overinfusion, or complete non-delivery of fluids.
  • Allegations state Baxter knew of device malfunctions, injuries, and deaths but provided inadequate remedial measures through customer alerts.
  • The firm claims Baxter's statements regarding product safety, efficacy, and sales prospects were materially false & misleading.
  • The alleged fraud was revealed on July 31, 2025, when Baxter voluntarily paused shipments & installations of the Novum LVP.
  • Baxter stock dropped 22.4 percent to close at $21.76 on July 31, 2025, following the announcement.
  • The deadline to seek the role of lead plaintiff in the federal class action is December 15, 2025.
  • James (Josh) Wilson encourages investors to contact the firm directly at 877-247-4292 or 212-983-9330 (Ext. 1310).
  • The firm is also seeking information from whistleblowers, former employees, & shareholders regarding Baxter's conduct.
  • Communications with the firm are treated as confidential.